InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Lapointe Anthony Gregg. Insider active across 2 companies, notably Rigel Pharmaceuticals INC. Aggregated, 5 disclosures have been recorded. Activity tracked since 19 May 2021. The latest transaction was filed on 23 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lapointe Anthony Gregg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
2,500 股0Common StockSEC:0000905148-25-001933:0
25,000 股0Common StockSEC:0000905148-24-001654:0
25,000 股0Common StockSEC:0001140361-23-034286:0
25,000 股0Common StockSEC:0001140361-22-020306:0
25,000 股0Common StockSEC:0001179110-21-005766:0
5 条申报中的 5 条
About Lapointe Anthony Gregg
LAPOINTE ANTHONY GREGG is a Director at RIGEL PHARMACEUTICALS INC and Rigel Pharmaceuticals INC. He has 5 filings in total, with the sampled recent filings spanning from 2021-05-21 to 2024-05-29, and those sampled filings indicate transactions of the Attribution type, with sum_buy_eur at 0 and sum_sell_eur at 0.
